Connecting phenotype to genotype: PheWAS-inspired analysis of autism spectrum disorder

Abstract

Autism Spectrum Disorder (ASD) is extremely heterogeneous clinically and genetically. There is a pressing need for a better understanding of the heterogeneity of ASD based on scientifically rigorous approaches centered on systematic evaluation of the clinical and research utility of both phenotype and genotype markers. This paper presents a holistic PheWAS-inspired method to identify meaningful associations between ASD phenotypes and genotypes. We generate two types of phenotype-phenotype (p-p) graphs: a direct graph that utilizes only phenotype data, and an indirect graph that incorporates genotype as well as phenotype data. We introduce a novel methodology for fusing the direct and indirect p-p networks in which the genotype data is incorporated into the phenotype data in varying degrees. The hypothesis is that the heterogeneity of ASD can be distinguished by clustering the p-p graph. The obtained graphs are clustered using network-oriented clustering techniques, and results are evaluated. The most promising clusterings are subsequently analyzed for biological and domain-based relevance. Clusters obtained delineated different aspects of ASD, including differentiating ASD-specific symptoms, cognitive, adaptive, language and communication functions, and behavioral problems. Some of the important genes associated with the clusters have previous known associations to ASD. We found that clusters based on integrated genetic and phenotype data were more effective at identifying relevant genes than clusters constructed from phenotype information alone. These genes included five with suggestive evidence of ASD association and one known to be a strong candidate.

Technical Report: Protocol for Characterizing Phenotype Variants Using Phenome-Wide Association Study (PheWAS) Utilizing the Nationwide Inpatient Sample 2020 in Individuals With Pancreatic Cysts and Lung Cancer

“…However, these are becoming more and more realities as electronic healthcare becomes more and more centralized. Future refinement, incorporating laboratory data, natural language processing, and machine learning algorithms, may improve case accuracy [ 12 ].…”

Subtypes of relapsing-remitting multiple sclerosis identified by network analysis

“…Network analysis has provided important insights in into brain connectivity, and neuroimaging ( 82 , 83 ). Network analysis has identified potential genetic causes of autism ( 84 ) and has clustered autism subjects by phenotype ( 85 , 86 ). Network analysis has been used to identify genes that govern MS susceptibility ( 87 – 89 ), proteins implicated in the etiology of MS ( 90 ), as well as brain areas that undergo disconnection in MS ( 45 , 91 – 93 ).…”

Unleashing the Potential of Artificial Bee Colony Optimized RNN-Bi-LSTM for Autism Spectrum Disorder Diagnosis

“…The long-term results for those with ASD are greatly improved by prompt intervention and specialized assistance, which are made possible by an early and precise diagnosis of the illness. Integrating cutting-edge technologies, including -BC optimization and RNN with BiLSTM, has emerged as a viable way to improve the diagnostic process in response to the urgent demand for more accurate and dependable diagnostic tools [8]. Traditionally, the ability of clinicians, psychologists, and other medical experts to evaluate behavioral observations, developmental histories, and clinical evaluations has been crucial in the diagnosis of ASD.…”